Featured
Last news
Cloud DX Ceases Trading
KITCHENER, ON / ACCESS Newswire / June 11, 2025 / Cloud DX Inc. ("Cloud DX") (TSXV:CDX)(OTCQB:CDXFF) reports that it has received a Cease Trade Order from the Ontario Securities Commission (OSC) on May 7, 2025. The order was issued due to the inability of the Company to file audited financial statements for FY2024.
New to The Street Launches New Broadcast Series Featuring Lahontan Gold Corp. (TSX-V: LG | OTCQB: LGCXF) and CEO Kimberly Ann Arntson
Filming Begins Thursday, June 12 at the New York Stock Exchange - Campaign Includes National TV Coverage, Earned Media, TV Commercials, and Full Social Media Amplification
NBJ Summit 2025 Brings Industry Visionaries Together to Shape Nutrition's Future
RANCHO PALOS VERDES, CA / ACCESS Newswire / June 11, 2025 / The nutrition and dietary supplements industry's premier gathering, NBJ Summit 2025, will convene top executives and thought leaders at the Terranea Resort in Rancho Palos Verdes, Calif. from July 28-31, 2025. With the central theme of "Nutrition Industry Transformation," this year's summit addresses the seismic shifts reshaping the nearly $70 billion dollar industry landscape. This year's event comes at a critical time, promising to mobilize leaders around topics presenting challenges and opportunities for consumers and the industry.
First Study Site Established for Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs
Two parallel goals for Canalevia-CA1 (crofelemer delayed-release tablets): To obtain full approval of the drug for treatment of chemotherapy-induced diarrhea (CID) and to expand the indication of crofelemer from CID to treatment of general, non-infectious diarrhea in dogsJaguar in discussions with potential partners to license and fund development and commercialization of crofelemer for the treatment of general, non-infectious diarrhea in dogs in the U.S. and/or globallyDiarrhea is one of the most common reasons for veterinary visits for dogs and the second most common reason for visits to the veterinary emergency room, yet there are currently no FDA-approved drugs to treat general diarrhea in dogs
Silver Scott Health, Inc. Introduces "Talk to a Nurse" 24/7 Service on AffordableTelehealthplan.com
FRANKLIN, NJ / ACCESS Newswire / June 11, 2025 / Silver Scott Health, Inc., a division of Silver Scott Mines, Inc. (OTC Pink:SILS), today announced the upcoming launch of its "Talk to a Nurse" feature on AffordableTelehealthplan.com. This new service will provide subscribers with unlimited 24/7 access to licensed nurses for health consultations, offering an affordable and convenient option for immediate health guidance and support.
NAB Show New York Set to Showcase the Tools and Technologies Driving Storytelling
Smosh CEO Alessandra Catanese Named First Keynote Speaker
Goldman Small Cap Research Issues New Research Update on OKYO Pharma Limited
Raising Price Target Due to Fundamental Drivers
SOHM Inc. Welcomes Dr. Larissa Karnaoukhova as New Vice President of Operations
CHINO HILLS, CA / ACCESS Newswire / June 11, 2025 / SOHM, Inc. (OTC PINK:SHMN), a leading pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, health and wellness solutions, proudly announces the appointment of Dr. Larissa Karnaoukhova, Ph.D, MBA, as Vice President of Operations. With extensive experience in site operations management, sales, and business development within highly regulated industries, Larissa will play a pivotal role in enhancing operational efficiency and driving strategic initiatives at SOHM Inc.
Telomir Pharmaceuticals Announces Telomir-1 Demonstrates Dose-Dependent Restoration of Neurological, Liver and Kidney Functions in Preclinical Wilson's Disease Model
Treatment reversed tremors, ataxia, anxiety-like behavior, liver and kidney pathology damage, reduced copper accumulation, normalized ALT, AST, and bilirubin levels, and improved survival.Building on previous data in Werner syndrome, showing Telomir-1 reset the epigenetic clock, extended telomere length, restored gene expression, reversed muscle loss, and rescued survival-alongside data in Age Related Macular Degeneration (AMD) demonstrating retinal regeneration and restored vision-the drug continues to show broad regenerative potential across rare genetic degenerative diseases
Dolphin Subsidiaries Shore Fire Media and The Digital Dept. Take Over CMA Fest 2025
NEW YORK, NY / ACCESS Newswire / June 11, 2025 / Shore Fire Media and The Digital Dept., subsidiaries of leading entertainment marketing and content production company Dolphin (NASDAQ:DLPN), significantly contributed to this year's CMA Fest with a full lineup of participating clients and events. Making its return to Nashville this past week, the festival welcomed country music fans from around the world for several days of live music and activations. A creative communications agency serving leaders in the arts, culture and entertainment, Shore Fire's clients Priscilla Block, Brooklyn Bowl, John Crist, Folds of Honor of Tennessee, Tyler Hubbard, Justin Moore, Brett Young, The War And Treaty, Wasserman Music and Warren Zeiders all participated in or hosted various performances, programs and events - while influencer marketing and talent management firm The Digital Dept. brought its experiential BRANDEdit event to Music City during the festival.
AGS Health(R) CEO Patrice Wolfe Named one of the Becker’s Healthcare "Top Women to Know in Health IT"
WASHINGTON, DC / ACCESS Newswire / June 11, 2025 / AGS Health® CEO Patrice Wolfe has been named to the Becker's Hospital Review list of "Women in Health IT to Know" in 2025. The annual list recognizes women who are harnessing the power of health IT to help shape the future of the healthcare industry.
Lexaria's DehydraTECH-Liraglutide Human GLP-1 Clinical Study Supports Pathway to Potential FDA Registration as an Orally-Delivered Capsule
Oral DehydraTECH-liraglutide showed a pronounced reduction in adverse events (“AEs”) as compared to injected liraglutide (Saxenda(R)) Lexaria has now demonstrated, in distinct human clinical studies, clear reductions in AEs utilizing its patented DehydraTECH technology with all of the three major GLP-1 drugs sold in the world today: liraglutide, semaglutide and tirzepatide
Sunshine Biopharma Launches Generic Gabapentin for Neuropathic Pain in the Canadian Segment of the Global $1.92 Billion Market
FORT LAUDERDALE, FL / ACCESS Newswire / June 11, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that its wholly owned Canadian subsidiary, Nora Pharma Inc., has launched Gabapentin, a new generic prescription drug in the therapeutic class of anticonvulsants.
Future of Batteries Summit 2025 to Accelerate US Energy Transition and Solid-State Battery Manufacturing
NEW YORK, NY / ACCESS Newswire / June 11, 2025 / New to The Street (NTTS) and High Performance Battery Technology (HPB) announce the launch of the Future of Batteries (FOB) Summit, an exclusive gathering in New York City for industry leaders ready to scale solid-state battery production in the United States. This inaugural summit with the theme, 'Bridging Innovation: From Proven European Battery Technology to Scalable US Manufacturing', will take place from June 17-19 in some of NYC's most exclusive locations.
CBD Life Sciences Inc. (CBDL) Reports 1,502.30% Revenue Increase from January to May 2025
Achieving a five-month revenue growth equivalent to an annualized rate exceeding 4,000%, as the booming CBD and mushroom supplement markets-projected to reach $30 billion and $15 billion respectively by 2028-fuel strong consumer demand and industry expansion.
Ensysce Biosciences Announces Speakers for Major Symposium at PAINWeek 2025
~ Pain Management, RE-Invented: A New Era for Analgesia ~
Interactive Strength Inc. (Nasdaq:TRNR) Enters into $500 Million Facility to Acquire AI-focused $FET Tokens and Launch Crypto Treasury Asset Strategy
ATW Partners and DWF Labs invested $55 million in initial closingTRNR is expected to have the largest US publicly listed crypto treasury focused on an AI-tokenTRNR enters into technology collaboration with Fetch.ai to power its fitness training with AI technology
Jerash Holdings to Report Financial Results for Fiscal 2025 Fourth Quarter and Full Year on Monday, June 23, 2025
FAIRFIELD, NJ / ACCESS Newswire / June 11, 2025 / Jerash Holdings (US), Inc. (NASDAQ:JRSH) (the "Company" or "Jerash"), which manufactures and exports custom, ready-made, sportswear and outerwear for leading global brands, today announced it will release its financial results for fiscal year ended March 31, 2025, before the market opens on Monday, June 23, 2025. The Company will host an investor conference call the same day.
Moderna to Present at Upcoming Barclays Speaking the Science Call Series on June 16, 2025
CAMBRIDGE, MA / ACCESS Newswire / June 11, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor event:
Cristina Kirchner: divisive left-winger tainted by fraud
During two decades at the forefront of Argentine politics, Cristina Kirchner inspired love and loathing in equal measure, but rarely indifference.
Argentine top court upholds ex-president Kirchner's prison sentence
Argentina's Supreme Court on Tuesday upheld the fraud conviction of ex-president Cristina Kirchner, for which she received a six-year prison sentence and was banned from holding public office for life.
Supporters ask to visit deported Venezuelans in Salvadoran jail
Supporters of Venezuelans deported by the United States to El Salvador, including one of their relatives, appealed to President Nayib Bukele's government Tuesday to let them see the migrants in prison.
Combs defense seeks to show ex had agency
Sean Combs's defense lawyers on Tuesday began questioning a woman who dated the music mogul up until his arrest, and who has testified in agonizing detail that he pressured her into drug-fueled sex with escorts.
Former student kills 10 people in Austrian high school shooting
A former student killed 10 people when he opened fire at a high school in southeastern Austria on Tuesday before taking his own life, authorities said, in an unprecedented case of deadly gun violence that stunned the Alpine country.
10 dead in Austria school shooting: mayor
Ten people died on Tuesday after a suspected shooter opened fire in a school in the southeastern Austrian city of Graz, the local mayor was quoted as saying.
Combs's ex to face scrutiny on the stand from music mogul's defense
Sean Combs's defense lawyers on Tuesday will question a woman who dated the music mogul up until his arrest, and who has testified in agonizing detail that he pressured her into drug-fueled sex with escorts.
Australian mushroom murder suspect denies covering tracks
An Australian woman accused of murdering three people with death cap mushrooms denied Tuesday that she was covering her tracks when she left hospital against medical advice for 95 minutes.
Relatives struggle to find last 1,000 Srebrenica victims 30 years on
Sadik Selimovic's relief at surviving the Srebrenica massacres 30 years ago did not last long.
Trump's cuts are 'devastating' for vulnerable women worldwide: UN
The United Nations Population Fund (UNFPA) has faced budget cuts before, but the impact of President Donald Trump's policies has been even more "devastating" for reproductive health worldwide, chief Natalia Kanem told AFP.
Avant Technologies and Partner, Ainnova, Finalizing Automated Retinal Camera Prototype Ahead of Full-Scale Development
LAS VEGAS, NEVADA / ACCESS Newswire / June 10, 2025 / Avant Technologies Inc. (OTCQB:AVAI) ("Avant" or the "Company"), and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced the Company is in the final stages of prototyping its proprietary automated retinal camera. Ainnova's new device will offer users a low cost, easier to use camera that captures images automatically and then uploads those images to the Company's Vision AI software platform, which then produces a "risk report" in mere seconds.
Prysmian Closes the Acquisition of Channell
HIGHLAND HEIGHTS, KY / ACCESS Newswire / June 10, 2025 / Prysmian, a world leader in the energy transition and digital transformation, has completed the acquisition of Channell Commercial Corporation ("Channell"), a leading U.S.-based manufacturer of thermoplastic enclosures and fiber management solutions, for a base purchase price of $950 million, subject to customary adjustments as set forth in the merger agreement. Under the terms of the merger agreement, Prysmian may also be required to make an additional potential payment of up to $200 million upon Channell's achievement of specified EBITDA performance targets for the 2025 calendar year.
Cordless Pet Feeder: ELECOM Introduces Rechargeable Ultra-Quiet Pet Fountain
New battery-powered model offers flexibility, quiet operation, and clean filtered water for pets anywhere in the home.